A detailed history of Assenagon Asset Management S.A. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 281,887 shares of PACB stock, worth $544,041. This represents 0.0% of its overall portfolio holdings.

Number of Shares
281,887
Previous 1,295,303 78.24%
Holding current value
$544,041
Previous $1.77 Million 73.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$1.2 - $2.17 $1.22 Million - $2.2 Million
-1,013,416 Reduced 78.24%
281,887 $479,000
Q2 2024

Jul 18, 2024

BUY
$1.36 - $3.65 $1.76 Million - $4.73 Million
1,295,303 New
1,295,303 $1.77 Million
Q4 2023

Jan 17, 2024

BUY
$5.97 - $10.36 $17.4 Million - $30.1 Million
2,909,439 Added 2201.04%
3,041,624 $29.8 Million
Q3 2023

Nov 06, 2023

BUY
$8.23 - $13.93 $1.09 Million - $1.84 Million
132,185 New
132,185 $1.1 Million
Q1 2023

Apr 18, 2023

SELL
$7.94 - $12.02 $1.9 Million - $2.87 Million
-238,838 Reduced 95.49%
11,292 $130,000
Q4 2022

Jan 12, 2023

SELL
$5.67 - $11.2 $3,090 - $6,104
-545 Reduced 0.22%
250,130 $2.05 Million
Q2 2022

Jul 27, 2022

BUY
$4.02 - $10.43 $1.01 Million - $2.61 Million
250,675 New
250,675 $1.11 Million
Q1 2022

Apr 25, 2022

SELL
$8.43 - $20.9 $411,569 - $1.02 Million
-48,822 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$19.26 - $30.08 $313,572 - $489,732
16,281 Added 50.03%
48,822 $999,000
Q3 2021

Oct 19, 2021

SELL
$24.86 - $35.02 $1.18 Million - $1.66 Million
-47,457 Reduced 59.32%
32,541 $831,000
Q2 2021

Jul 15, 2021

SELL
$22.3 - $36.02 $12.1 Million - $19.6 Million
-543,073 Reduced 87.16%
79,998 $2.8 Million
Q1 2021

Apr 26, 2021

SELL
$26.38 - $51.15 $342,860 - $664,796
-12,997 Reduced 2.04%
623,071 $20.8 Million
Q4 2020

Feb 01, 2021

SELL
$10.5 - $28.5 $2.46 Million - $6.67 Million
-234,203 Reduced 26.91%
636,068 $16.5 Million
Q3 2020

Oct 07, 2020

SELL
$3.61 - $9.87 $429,275 - $1.17 Million
-118,913 Reduced 12.02%
870,271 $8.59 Million
Q2 2020

Jul 21, 2020

SELL
$2.65 - $4.03 $1.44 Million - $2.18 Million
-542,166 Reduced 35.4%
989,184 $3.41 Million
Q1 2020

Apr 17, 2020

BUY
$2.36 - $5.26 $3.61 Million - $8.05 Million
1,531,350 New
1,531,350 $4.69 Million
Q4 2019

Jan 17, 2020

SELL
$4.6 - $5.57 $4.51 Million - $5.46 Million
-980,997 Closed
0 $0
Q3 2019

Oct 16, 2019

BUY
$4.99 - $6.16 $4.9 Million - $6.04 Million
980,997 New
980,997 $5.06 Million
Q1 2019

Apr 26, 2019

SELL
$6.8 - $7.4 $790,853 - $860,634
-116,302 Closed
0 $0
Q4 2018

Jan 23, 2019

BUY
$3.99 - $7.82 $464,044 - $909,481
116,302 New
116,302 $861,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $434M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.